Dr. Guyer has been very active with various spine societies including North American Spine Society (NASS), Cervical Spine Research Society (SSRS), International Society for the Study of the Lumbar Spine (ISSLS), and International Society for the Advancement of Spine Surgery (ISASS) serving as President of NASS during the 2006-2007 year and various committees of the ISASS. He was recently appointed to the board of directors of the American Board of Spinal Surgery.
Philip Messina, President and CEO said, "We are very pleased to welcome Dr. Guyer to our Scientific Advisory Board. He is considered to be among the top spine surgeons in the world. We could not be more pleased to have him on board. "
C. Timothy Floyd, MD, Chief Scientific Officer and Chair of the Scientific Advisory Board said, "Dr. Guyer is a world leader in cutting edge spine surgery and techniques. His counsel, as we move into our global clinical trial on SURGICLOT will be important."
About St. Teresa
St. Teresa Medical, Inc.®, based in St. Paul, MN., is a medical-device company developing SURGICLOT®, a new unique dissolvable hemostatic dressing for use during orthopedic surgery. SURGICLOT® is uniquely fabricated from nanoscale electro-spun dextran fibers infused with fibrinogen and thrombin. SURGICLOT® works by supplementing and enhancing the body's natural clotting mechanism. SURGICLOT® utilizes thrombin and fibrinogen obtained from human sources.
For more information, see www.StTeresaMedical.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/st-teresa-medical-inc-announces-appointment-of-richard-guyer-md-to-scientific-advisory-board-300322887.html
SOURCE St. Teresa Medical, Inc.